Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antibiotic   Cefazolin sodium  
Injection
Eye-drops
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Acef Italy
Ancef United States of America
Basocef Germany
Biofazolin Poland
Brizolina Spain
Cecan Peru
Cefabiozim Italy
Cefacidal Chile, Colombia, Luxembourg, Mexico, Morocco, Netherlands
Cefadin India
Cefamezin Tunisia
Cefazil Italy
Cefozin Turkey
Cromezin Italy
Eqizolin Turkey
Fazoplex Spain
Intrazolina Spain
Kefzol Austria, Belgium, Switzerland
Kurgan Spain
Nefazol Italy
Recef Italy
Sefamax Turkey
Sefazol Turkey
Sicef Italy
Tasep Spain
Tecfazolina Spain
Totacef Italy
Vifazolin Greece
Zepilen Thailand
Zolicef Austria
Zolival Spain
Stability of mixtures   Injection   Stability of mixtures : Cefazolin sodium     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 10 mg/ml
Injection   Cefazolin sodium   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass NaCl 0,9% or Glucose 5% 10 mg/ml
Injection   Cefazolin sodium   
Injection   Clindamycin phosphate 9 mg/ml
25°C
48 Hour
Light 418
Level of evidence D
Glass Sodium chloride 0,9% 10 mg/ml
Injection   Cefazolin sodium   
Injection   Clindamycin phosphate 9 mg/ml
Injection   Gentamicin sulfate 0,8 mg/ml
25°C
12 Hour
Light 695
Joker
Glass Sodium chloride 0,9% 20 mg/ml
Injection   Cefazolin sodium   
Injection   Ranitidine hydrochloride 0,5 mg/ml
25°C
4 Hour
2355
Level of evidence D
Glass Glucose 5% 5 mg/ml
Injection   Cefazolin sodium   
Injection   Magnesium sulfate 10 & 20 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Glass Glucose 5% 10 mg/ml
Injection   Cefazolin sodium   
Injection   Clindamycin phosphate 9 mg/ml
Injection   Gentamicin sulfate 0,8 mg/ml
25°C
1 Hour
Light 695
Joker
Glass Glucose 5% 10 mg/ml
Injection   Cefazolin sodium   
Injection   Palonosetron hydrochloride 25 µg/ml
25°C
4 Hour
2214
Level of evidence A+
Glass Ringer’s lactate solution 10 mg/ml
Injection   Cefazolin sodium   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass Sodium chloride 0,45% 10 mg/ml
Injection   Cefazolin sodium   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass None 10 mg/ml
Injection   Cefazolin sodium   
Injection   Metronidazole 5 mg/ml
25°C
7 Day
Protect from light 631
Level of evidence D
Glass None 10 mg/ml
Injection   Cefazolin sodium   
Injection   Metronidazole 5 mg/ml
5°C
12 Day
Protect from light 631
Level of evidence D
Glass None 10 mg/ml
Injection   Cefazolin sodium   
Injection   Metronidazole 5 mg/ml
8°C
3 Day
Protect from light 671
Level of evidence C
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 & 20 mg/ml
Injection   Cefazolin sodium   
Injection   Aztreonam 10 & 20 mg/ml
23°C-25°C
48 Hour
Protect from light 426
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 & 20 mg/ml
Injection   Cefazolin sodium   
Injection   Aztreonam 10 & 20 mg/ml
4°C-5°C
7 Day
Protect from light 426
Level of evidence A
Polyvinyl chloride Glucose 5% 5 mg/ml
Injection   Cefazolin sodium   
Injection   Tenoxicam 0,2 mg/ml
4°C
72 Hour
Not specified 1951
Level of evidence B
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
Injection   Cefazolin sodium   
Injection   Ceftazidime 0,5 mg/ml
25°C
2 Day
Protect from light 3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
Injection   Cefazolin sodium   
Injection   Gentamicin sulfate 0,02 mg/ml
25°C
4 Day
Protect from light 3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0,125 mg/ml
Injection   Cefazolin sodium   
Injection   Ceftazidime 0,125 mg/ml
25°C
24 Hour
Not specified 3651
Level of evidence C
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
Injection   Cefazolin sodium   
Injection   Ceftazidime 0,5 mg/ml
37°C
24 Hour
Protect from light 3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
Injection   Cefazolin sodium   
Injection   Gentamicin sulfate 0,02 mg/ml
37°C
24 Hour
Protect from light 3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0,125 mg/ml
Injection   Cefazolin sodium   
Injection   Ceftazidime 0,125 mg/ml
37°C
24 Hour
Not specified 3651
Level of evidence C
Polyvinyl chloride Extraneal® (Baxter) 0,125 mg/ml
Injection   Cefazolin sodium   
Injection   Ceftazidime 0,125 mg/ml
4°C
7 Day
Protect from light 3651
Level of evidence C
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
Injection   Cefazolin sodium   
Injection   Ceftazidime 0,5 mg/ml
4°C
14 Day
Protect from light 3888
Level of evidence D
Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml
Injection   Cefazolin sodium   
Injection   Gentamicin sulfate 0,02 mg/ml
4°C
14 Day
Protect from light 3888
Level of evidence D
Polyolefine None 10 mg/ml
Injection   Cefazolin sodium   
Injection   Linezolid 2 mg/ml
23°C
3 Day
Protect from light 1659
Level of evidence A+
Polyolefine None 10 mg/ml
Injection   Cefazolin sodium   
Injection   Linezolid 2 mg/ml
4°C
7 Day
Protect from light 1659
Level of evidence A+
  Mentions Légales